Temsirolimus in Myelodysplastic Syndrome (MDS)

NCT01111448 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Unfavourable Risk-Benefit-Ratio

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Temsirolimus

Sponsor

Technische Universität Dresden

Collaborators

[object Object]